News

Pfizer's sickle-cell treatment efforts falter as drug fails study

In the latest setback for Pfizer's sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal ...

FDA Accepts Pfizer (PFE) Vepdegestrant NDA for Breast Cancer, Fast Track Designation Awarded

Pfizer (PFE) recently announced that the U.S. Food and Drug Administration accepted the New Drug Application for ...
Medical Marketing & Media1d

Rx Rundown: Bayer, BlinkRx, Pfizer and more

AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...

Pfizer's sickle cell drug fails late-stage trial

Pfizer's experimental drug to treat sickle cell anemia failed to meet the main goal in a late stage trial, the drugmaker said ...
CURE3d

FDA Accepts NDA for Vepdegestrant in ESR1+ Advanced Breast Cancer

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

The FDA let substandard factories ship these medications to the U.S.

This story was originally published by ProPublica, a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story ...